9:30

Invited Comments from Mary McCabe, Memorial Sloan-Kettering Cancer Survivorship Program

9:35

Therapy for Advanced-Stage Cancer: What Do Patients Want and Expect?

Speaker: Robert Erwin, Marti Nelson Cancer Foundation

10:05

Invited Comments from Ellen Stovall, National Coalition for Cancer Survivorship

10:10

Discussion

10:40

10-Minute Break

10:50

Generating Evidence About Effectiveness and Value

Moderator: Steven B. Cohen, Agency for Healthcare Research and Quality

10:55

FDA Perspectives on Evidence for Regulatory Approval in Cancer

Speaker: Janet Woodcock, Food and Drug Administration

11:25

What Constitutes Reasonable Evidence of Efficacy and Effectiveness?

Speaker: Daniel J. Sargent, Mayo Clinic

11:55

Discussion

12:25 p.m.

Lunch

1:00

Value and the Oncology Market

Moderator: Jeffrey C. Lerner, ECRI Institute

1:05

Drug Pricing and Value in Oncology vs. Other Areas in Medicine

Speaker: Patricia M. Danzon, University of Pennsylvania

1:35

Industry Perspective on Pharmaceutical Pricing in Oncology

Speaker: Greg Rossi, Genentech, Inc.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement